A Czech scientist from the Central European Institute of Technology (CEITEC) has revealed a new discovery on DNA which could lead to more effective treatment for some forms of hereditary breast and ovarian cancer.
Michal Zimmermann's study has revealed that the loss or mutation of the Rif1 gene can make cancer cells more resistant to treatments and reverse chemotherapy's effects.
Currently, scientists are working on a new form of chemotherapy for hereditary breast and o...
This story is part of New Europe's Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|